Stephen I. Rennard

1979–2025 年に発表

226
論文数
48,015
被引用数
118
h 指数
225
i10 指数

被引用数

Stephen I. Rennard の年別被引用数1979 年: 被引用 3 件1980 年: 被引用 29 件1981 年: 被引用 72 件1982 年: 被引用 89 件1983 年: 被引用 86 件1984 年: 被引用 95 件1985 年: 被引用 97 件1986 年: 被引用 111 件1987 年: 被引用 96 件1988 年: 被引用 109 件1989 年: 被引用 93 件1990 年: 被引用 108 件1991 年: 被引用 85 件1992 年: 被引用 63 件1993 年: 被引用 67 件1994 年: 被引用 58 件1995 年: 被引用 70 件1996 年: 被引用 69 件1997 年: 被引用 59 件1998 年: 被引用 105 件1999 年: 被引用 123 件2000 年: 被引用 127 件2001 年: 被引用 121 件2002 年: 被引用 163 件2003 年: 被引用 184 件2004 年: 被引用 206 件2005 年: 被引用 197 件2006 年: 被引用 273 件2007 年: 被引用 251 件2008 年: 被引用 245 件2009 年: 被引用 269 件2010 年: 被引用 282 件2011 年: 被引用 354 件2012 年: 被引用 379 件2013 年: 被引用 369 件2014 年: 被引用 399 件2015 年: 被引用 347 件2016 年: 被引用 317 件2017 年: 被引用 346 件2018 年: 被引用 306 件2019 年: 被引用 1,137 件2020 年: 被引用 1,106 件2021 年: 被引用 1,024 件2022 年: 被引用 800 件2023 年: 被引用 608 件2024 年: 被引用 860 件2025 年: 被引用 375 件2026 年: 被引用 11 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,272 件、この内訳の 27.1%イギリス: 引用元論文 1,774 件、この内訳の 11.3%ドイツ: 引用元論文 786 件、この内訳の 5%カナダ: 引用元論文 771 件、この内訳の 4.9%中国: 引用元論文 757 件、この内訳の 4.8%イタリア: 引用元論文 664 件、この内訳の 4.2%オランダ: 引用元論文 650 件、この内訳の 4.1%スペイン: 引用元論文 635 件、この内訳の 4%オーストラリア: 引用元論文 486 件、この内訳の 3.1%フランス: 引用元論文 435 件、この内訳の 2.8%日本: 引用元論文 376 件、この内訳の 2.4%スウェーデン: 引用元論文 364 件、この内訳の 2.3%
0%27.1%その他 24%

分野

  • Medicine75%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Immunology and Microbiology2.8%
  • Neuroscience1.4%
  • Environmental Science1.2%
  • Health Professions1%
  • その他3.8%

トピック

  • Chronic Obstructive Pulmonary Disease (COPD) Research15.2%
  • Asthma and respiratory diseases6.5%
  • Respiratory Support and Mechanisms4.5%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis2.9%
  • Respiratory and Cough-Related Research2.4%
  • Cell Adhesion Molecules Research2.2%
  • その他66.3%

共著者

全論文

検索で開く
  1. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2010 被引用: 2,979

  2. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 690

  3. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials

    著者: , , , , , , - The Lancet Respiratory Medicine 2018 被引用: 440

  4. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2004 被引用: 4,434

  5. Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

    著者: , , , , , , , , , , , , , , , , , - PLoS ONE 2012 被引用: 850

  6. CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease

    著者: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2015 被引用: 258

  7. Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook

    著者: , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 104

  8. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David A. Lomas, Stephanie J. London, Deborah A. Meyers, George O'connor, Stephen I. Rennard, David A. Schwartz, Paweł Śliwiński, David Sparrow, David P. Strachan, Ruth Tal‐Singer, Yohannes Tesfaigzi, Jørgen Vestbo, Judith M. Vonk, Jae‐Joon Yim, Xiaobo Zhou, Yohan Bossé, Ani Manichaikul, Lies Lahousse, Edwin K. Silverman, H. Marike Boezen, Louise V. Wain, Martin D. Tobin, Brian D. Hobbs, Michael H. Cho, Nick Shrine, Anna L. Guyatt, Chiara Batini, Jing Hua Zhao, Matthias Wielscher, Understanding Society Scientific Group, Stefan Weiß, Katherine A. Kentistou, James P. Cook, Jennie Hui, Stefan Karrasch, Medea Imboden, Sarah E. Harris, Jonathan Marten, Stefan Enroth, Shona M. Kerr, Ida Surakka, Véronique Vitart, Terho Lehtimäki, Ralf Ewert, Christian Gieger, Georg Homuth, Peter K. Joshi, Claudia Langenberg, Lars Lind, Jian’an Luan, Anubha Mahajan, Alison D. Murray, David J. Porteous, Rajesh Rawal, Blair H. Smith, Paul R. H. J. Timmers, Olli Raitakari, Mika Kähönen, Ozren Polašek, Ulf Gyllensten, Igor Rudan, Ian J. Deary, Nicole Probst‐Hensch, Holger Schulz, Alan L. James, James F. Wilson, Beate Stubbe, Eleftheria Zeggini, Marjo‐Riitta Järvelin, Nick Wareham ほか 89 名 - Nature Genetics 2019 被引用: 423

  9. Changes in Forced Expiratory Volume in 1 Second over Time in COPD

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 被引用: 958

  10. At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2018 被引用: 280

  11. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1

    著者: , , , , , , , , , , - Thorax 2013 被引用: 402

  12. SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs

    著者: , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 被引用: 255

  13. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Russell P. Bowler, Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P Comellas, Christopher B. Cooper, David Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martínez, Deborah A. Meyers, John D. Newell, Elizabeth C. Oelsner, Wanda K. O’Neal, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff - The Lancet Respiratory Medicine 2017 被引用: 318

  14. Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels

    著者: , , , , , , , , , , , , - American Journal of Physiology-Lung Cellular and Molecular Physiology 2014 被引用: 221

  15. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P Comellas, Christopher B. Cooper, David Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martínez, Deborah A. Meyers, John D. Newell, Elizabeth C. Oelsner, Wanda K. O’Neal, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff - The Lancet Respiratory Medicine 2017 被引用: 317

  16. Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

    著者: , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2012 被引用: 430

  17. Early chronic obstructive pulmonary disease: definition, assessment, and prevention

    著者: , - The Lancet 2015 被引用: 269

  18. Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Judith García‐Aymerich, Thierry Troosters - Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation 2021 被引用: 95

  19. Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease

    著者: , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 101

  20. Quantitative Computed Tomography Measures of Pectoralis Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease. A Cross-Sectional Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the American Thoracic Society 2014 被引用: 248

  21. Reconsidering the Utility of Race-Specific Lung Function Prediction Equations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 被引用: 109

  22. Small airway determinants of airflow limitation in chronic obstructive pulmonary disease

    著者: , , , , , , , , , - Thorax 2021 被引用: 56

  23. Outcomes for COPD pharmacological trials: from lung function to biomarkers

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2008 被引用: 857

  24. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthijs Oudkerk, Harry J.M. Groen, Nicholas Locantore, Ruth Tal‐Singer, Stephen I. Rennard, Jørgen Vestbo, Wim Timens, Peter D. Paré, Jeanne C. Latourelle, Josée Dupuis, George O'connor, Jemma B. Wilk, Woo Jin Kim, Mi Kyeong Lee, Yeon‐Mok Oh, Judith M. Vonk, Harry J. de Koning, Shuguang Leng, Steven A. Belinsky, Yohannes Tesfaigzi, Ani Manichaikul, Xin‐Qun Wang, Stephen S. Rich, R. Graham Barr, David Sparrow, Augusto A. Litonjua, Per Bakke, Amund Gulsvik, Lies Lahousse, Guy Brusselle, Bruno H. Stricker, André G. Uitterlinden, Elizabeth J. Ampleford, Eugene R. Bleecker, Prescott G. Woodruff, Deborah A. Meyers, Dandi Qiao, David A. Lomas, Jae‐Joon Yim, Deog Kyeom Kim, I Hawryłkiewicz, Paweł Śliwiński, Megan Hardin, Tasha E. Fingerlin, David A. Schwartz, Dirkje S. Postma, William MacNee, Martin D. Tobin, Edwin K. Silverman, H. Marike Boezen, Michael H. Cho - Nature Genetics 2017 被引用: 442